Maternal thyroid disease, thyroid medication use, and selected birth defects in the national birth defects prevention study

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 7, 2009, Pages 621-628

  Browne, Marilyn L ^a,h   Rasmussen, Sonja A ^b   Hoyt, Adrienne T ^a   Waller, D Kim ^c   Druschel, Charlotte M ^a   Caton, Alissa R ^a   Canfield, Mark A ^d   Lin, Angela E ^e   Carmichael, Suzan L ^f   Romitti, Paul A ^g  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f March of Dimes Birth Defects Foundation   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h NONE   (United States)

Author keywords

Birth defects; Congenital abnormalities; Thyroid disease; Thyroid hormones; Thyroxine

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

ADOLESCENT; ADULT; ANUS ATRESIA; ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYDROCEPHALUS; HYPOSPADIAS; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MEDICAL INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TELEPHONE; THYROID DISEASE;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; CHILD; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; THYROID DISEASES;

EID: 67651172904     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20573     Document Type: Article

References (23)

1. Adams MM, Mulinare J, Dooley K. 1989. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol 14:432-442. (Pubitemid 19199769)
2. Akita S, Nakamura T, Hirano A, et al. 1994. Thyroid hormone action on rat calvarial sutures. Thyroid 4:99-106. (Pubitemid 24145894)
3. Becks GP, Burrow GN. 1991. Thyroid disease and pregnancy. Med Clin North Am 75:121-150.
4. Botto LD, Lin AE, Riehle-Colarusso T, et al. 2007. Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79:714-727. (Pubitemid 47584196)
5. Cedergren MI, Selbing AJ, Kallen BA. 2002. Risk factors for cardiovascular malformation-a study based on prospectively collected data. Scand J Work Environ Health 28:12-17.
6. Cohen MM Jr. 2002. Malformations of the craniofacial region: evolutionary, embryonic, genetic, and clinical perspectives. Am J Med Genet 115:245-268.
7. Correa A, Gilboa SM, Besser LM, et al. 2008. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199:237-239.
8. Daneman D, Howard NJ. 1980. Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr 97:257-259. (Pubitemid 10056304)
9. de Lima MA, Oliveira LB, Paim N, Borges MF. 1999. Congenital hyperthyroidism: autopsy report. Rev Hosp Clin Fac Med Sao Paulo 54: 103-106.
10. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. 1997. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington infant study, 1981-1989 Vol 5. Armonk, NY: Futura.
11. Heinonen OP, Slone D, Shapiro S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group.
12. Ioannidis JP. 2008. Why most discovered true associations are inflated. Epidemiology 19:640-648.
13. Karabinas CD, Tolis GJ. 1998. Thyroid disorders and pregnancy. J Obstet Gynaecol 18:509-515.
14. Khoury MJ, Becerra JE, d'Almada PJ. 1989. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol 3:402-420.
15. Klein RZ, Haddow JE, Faix JD et al. 1991. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 35:41-46.
16. Nielsen GL, Norgard B, Puho E, et al. 2005. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med 22: 693-696. (Pubitemid 40805888)
17. Poppe K, Glinoer D, Van SA, et al. 2002. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 12:997-1001. (Pubitemid 35404134)
18. Queisser-Luft A, Eggers I, Stolz G, et al. 1996. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet 63:268-276. (Pubitemid 26147453)
19. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67:193-201.
20. Rasmussen SA, Yazdy MM, Carmichael SL, et al. 2007. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 110: 369-377. (Pubitemid 47356663)
21. Schroeder BM. 2002. ACOG practice bulletin on thyroid disease in pregnancy. Am Fam Physician 65:2158, 2161-2162.
22. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep. 116 (Suppl 1):32-40. (Pubitemid 32822091)
23. Zoeller RT, Bansal R, Parris C. 2005. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 146:607-612. (Pubitemid 40129816)